Cape, Elgine .
HRN: 29-23-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
METRONIDAZOLE 500MG (TAB)
07/14/2026
07/21/2026
PO
500mg
Q8
Thickly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes